Trajectories of Antiretroviral Therapy Adherence and Virologic Failure in Women With HIV in the United States
暂无分享,去创建一个
Mardge H. Cohen | A. Adimora | D. Jacobson | M. Plankey | J. Haberer | Michael F. Schneider | B. Tamraz | D. Jones | M. Ghebremichael | D. Konkle-Parker | T. Wilson | A. Adedimeji | A. I. Elbur | Shelby Collins | Michael F. Schneider
[1] L. Brown,et al. A Review of Interventions to Enhance HIV Medication Adherence , 2021, Current HIV/AIDS Reports.
[2] J. Mermin,et al. Estimated Annual Number of HIV Infections ─ United States, 1981–2019 , 2021, MMWR. Morbidity and mortality weekly report.
[3] O. Mgbere,et al. Evaluation of the Sociodemographic, Behavioral and Clinical Influences on Complete Antiretroviral Therapy Adherence Among HIV-Infected Adults Receiving Medical Care in Houston, Texas , 2021, HIV/AIDS.
[4] E. Miller,et al. Mental Health in Women Living With HIV: The Unique and Unmet Needs , 2021, Journal of the International Association of Providers of AIDS Care.
[5] E. Weld. Limits of Detection and Limits of Infection: Quantitative HIV Measurement in the Era of U = U. , 2020, The journal of applied laboratory medicine.
[6] D. Holdford,et al. Medication Adherence Trajectories: A Systematic Literature Review , 2020, Journal of managed care & specialty pharmacy.
[7] R. Savage,et al. Feasibility, acceptability, and preliminary impact of telemedicine-administered cognitive behavioral therapy for adherence and depression among African American women living with HIV in the rural South , 2020, Journal of health psychology.
[8] L. Mesana,et al. Antiretroviral Adherence, Drug Resistance, and the Impact of Social Determinants of Health in HIV-1 Patients in the US , 2020, AIDS and Behavior.
[9] J. Haberer,et al. Approaches to Objectively Measure Antiretroviral Medication Adherence and Drive Adherence Interventions , 2020, Current HIV/AIDS Reports.
[10] Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV , 2020 .
[11] C. Armon,et al. Disparities in Viral Suppression and Medication Adherence among Women in the USA, 2011–2016 , 2019, AIDS and Behavior.
[12] Mardge H. Cohen,et al. Viremia Trajectories of HIV in HIV-Positive Women in the United States, 1994-2017 , 2019, JAMA network open.
[13] Jennifer A. Pellowski,et al. A Systematic Review and Meta-analysis of Antiretroviral Therapy (ART) Adherence Interventions for Women Living with HIV , 2018, AIDS and Behavior.
[14] G. Wagner,et al. Antiretroviral Adherence Trajectories Among Black Americans Living with HIV , 2018, AIDS and Behavior.
[15] Gina Wingood,et al. Cohort Profile: The Women's Interagency HIV Study (WIHS). , 2018, International journal of epidemiology.
[16] M. Friend,et al. Estimated HIV incidence and prevalence in the United States 2010–2015 , 2018 .
[17] P. Anderson,et al. Inflammation and pharmacokinetics: potential implications for HIV-infection , 2017, Expert opinion on drug metabolism & toxicology.
[18] Aaron N. Winn,et al. The association between trajectories of endocrine therapy adherence and mortality among women with breast cancer , 2016, Pharmacoepidemiology and drug safety.
[19] S. Eholie,et al. Antiretroviral treatment regardless of CD4 count: the universal answer to a contextual question , 2016, AIDS Research and Therapy.
[20] V. Rivera-Amill,et al. Impact of Depression and Inflammation on the Progression of HIV Disease , 2016, Journal of clinical & cellular immunology.
[21] S. Perera,et al. Trajectories of Diabetes Medication Adherence and Hospitalization Risk: A Retrospective Cohort Study in a Large State Medicaid Program , 2016, Journal of General Internal Medicine.
[22] W. Andiman,et al. Frequent Episodes of Detectable Viremia in HIV Treatment-Experienced Children is Associated with a Decline in CD4+ T-cells Over Time. , 2016, Journal of AIDS & clinical research.
[23] Jeffrey N. Martin,et al. Duration of Antiretroviral Therapy Adherence Interruption Is Associated With Risk of Virologic Rebound as Determined by Real-Time Adherence Monitoring in Rural Uganda , 2015, Journal of acquired immune deficiency syndromes.
[24] A. Carrico,et al. Unhealthy Alcohol Use is Associated with Monocyte Activation Prior to Starting Antiretroviral Therapy. , 2015, Alcoholism, clinical and experimental research.
[25] T. Brennan,et al. Association between trajectories of statin adherence and subsequent cardiovascular events , 2015, Pharmacoepidemiology and drug safety.
[26] Blair T. Johnson,et al. Health Behavior Change Models for HIV Prevention and AIDS Care: Practical Recommendations for a Multi-Level Approach , 2014, Journal of acquired immune deficiency syndromes.
[27] K. Arheart,et al. Tobacco Smoking Increases Immune Activation and Impairs T-Cell Function in HIV Infected Patients on Antiretrovirals: A Cross-Sectional Pilot Study , 2014, PloS one.
[28] G. Peterson,et al. Barriers and Facilitators of Adherence to Antiretroviral Drug Therapy and Retention in Care among Adult HIV-Positive Patients: A Qualitative Study from Ethiopia , 2014, PloS one.
[29] Mardge H. Cohen,et al. Understanding the Disparity: Predictors of Virologic Failure in Women Using Highly Active Antiretroviral Therapy Vary by Race and/or Ethnicity , 2013, Journal of acquired immune deficiency syndromes.
[30] Daniel S. Nagin,et al. A Note on a Stata Plugin for Estimating Group-based Trajectory Models , 2012 .
[31] P. Harrigan,et al. Risk of Viral Failure Declines With Duration of Suppression on Highly Active Antiretroviral Therapy Irrespective of Adherence Level , 2010, Journal of acquired immune deficiency syndromes.
[32] Daniel S Nagin,et al. Group-based trajectory modeling in clinical research. , 2010, Annual review of clinical psychology.
[33] A. Applebaum,et al. Gender and Other Psychosocial Factors as Predictors of Adherence to Highly Active Antiretroviral Therapy (HAART) in Adults with Comorbid HIV/AIDS, Psychiatric and Substance-related Disorder , 2009, AIDS and Behavior.
[34] J. Parsons,et al. Motivational Interviewing and Cognitive-Behavioral Intervention to Improve HIV Medication Adherence Among Hazardous Drinkers: A Randomized Controlled Trial , 2007, Journal of acquired immune deficiency syndromes.
[35] W. Hauck,et al. Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users , 2003, Journal of General Internal Medicine.
[36] Ann E. Kurth,et al. Self-Report Measures of Antiretroviral Therapy Adherence: A Review with Recommendations for HIV Research and Clinical Management , 2006, AIDS and Behavior.
[37] M. Young,et al. The Women's Interagency HIV Study: an Observational Cohort Brings Clinical Sciences to the Bench , 2005, Clinical Diagnostic Laboratory Immunology.
[38] Marcus H Snow,et al. HIV viral suppression in the era of antiretroviral therapy , 2003, Postgraduate medical journal.
[39] Joseph Feldman,et al. The Women's Interagency HIV Study , 1998 .
[40] L. Radloff. The CES-D Scale: A Self-Report Depression Scale for Research in the General Population — Source link , 2022 .